CureVac N.V. (NASDAQ:CVAC) saw a downside of -7.81% to $39.80 after subtracting -$3.37 on Tuesday. The 5-day average trading volume is 657,689 shares of the company’s common stock. It has gained $45.16 in the past week. An average of 647,107 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 675,921.
CVAC’s 1-month performance is -36.03% or -$27.44 on its low of $37.54 reached on 10/12/21. The company’s shares have touched a 52-week low of $42.44 and high of $151.80, with the stock’s rally to the 52-week high happening on 02/08/21. YTD, CVAC has lost -46.75% or -$41.03. However, the current price is down -73.78%% from the 52-week high price.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
CureVac N.V. (CVAC) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.23 for the sector.CVAC stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 161.04.
For the quarterly period ending December 30 this year, Analysts expected CVAC to announce -$0.61 per share in earnings in its latest quarter, but it posted -$0.38, representing a 37.70% surprise. CVAC stock balance sheet for the quarter ending December 30 shows that, with total debt at $55.28 million
Let’s look briefly at CureVac N.V. (CVAC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 18.16% to suggest the stock is trending oversold, with historical volatility in this time period at 83.09%.
The stock’s 5-day moving average is $42.75, reflecting a -8.77% or -$3.85 change from its current price. CVAC is currently trading -34.09% above its 20-day SMA, -65.17% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -19.74% and -60.64% respectively.
Stochastic %K and %D was 8.32% and 7.63% and the average true range (ATR) pointed at 3.15. The RSI (14) points at 23.94%, while the 14-day stochastic is at 12.01% with the period’s ATR at 3.26. The stock’s 9-day MACD Oscillator is pointing at -2.36 and -6.62 on the 14-day charts.
In the most recent analyst report for CureVac N.V. (NASDAQ: CVAC), BofA Securities downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for CVAC stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate CVAC as a “sell,”, while 3 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is CVAC’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $44.96 and a high of $106.07, with their median price target at $55.14. Looking at these predictions, the average price target given by analysts is for CureVac N.V. (CVAC) stock is $68.72.